EUVIMEDEUVIMED entdecken
Open Access

Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease

Robert X Smith, Jeremy F Strain, Aaron Tanenbaum, Anne M Fagan, Jason Hassenstab, Eric McDade, Suzanne E Schindler, Brian A Gordon, Chengjie Xiong, Jasmeer Chhatwal, Clifford Jack, Celeste Karch und 19 weitere

Brain Connectivity · 01.04.2021 · 11 (3) · 239-249

DOI: 10.1089/brain.2020.0808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Connectivity, erschienen am 01.04.2021. Verfasst von Robert X Smith und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINR NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesBiomarkersBrainCross-Sectional StudiesHumansMagnetic Resonance ImagingPositron-Emission Tomography

Stichwörter der Autor:innen

18F-fluorodeoxyglucose (FDG)amyloidautosomal dominant Alzheimer diseasecerebrospinal fluid (CSF)estimated years to onset (EYO)hippocampuspositron emission tomography (PET)resting-state functional connectivitytau

Substanzen

Amyloid beta-PeptidesBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Washington University in Saint Louis, St. Louis, Missouri, USA.
  • Hope Center for Neurological Disorders, Knight ADRC, Washington University, St. Louis, Missouri, USA.
  • Department of Radiology, Washington University in Saint Louis, St. Louis, Missouri, USA.
  • Department of Biostatistics, Washington University in Saint Louis, St. Louis, Missouri, USA.
  • Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

Förderung

  • NIA NIH HHS
  • NINR NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Smith, R. X., Strain, J. F., Tanenbaum, A., Fagan, A. M., Hassenstab, J., McDade, E., Schindler, S. E., Gordon, B. A., Xiong, C., Chhatwal, J., Jack, C., Karch, C., Berman, S., Brosch, J. R., Lah, J. J., Brickman, A. M., Cash, D. M., Fox, N. C., Graff-Radford, N. R., …, & Ances, B. M. (2021). Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease. Brain Connectivity, 11(3), 239-249. https://doi.org/10.1089/brain.2020.0808

Vancouver

Smith RX, Strain JF, Tanenbaum A, Fagan AM, Hassenstab J, McDade E, et al. Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease. Brain Connectivity. 2021;11(3):239-249. doi:10.1089/brain.2020.0808

BibTeX
@article{Smith2021,
  author = {Smith, Robert X and Strain, Jeremy F and Tanenbaum, Aaron and Fagan, Anne M and Hassenstab, Jason and McDade, Eric and Schindler, Suzanne E and Gordon, Brian A and Xiong, Chengjie and Chhatwal, Jasmeer and Jack, Clifford and Karch, Celeste and Berman, Sarah and Brosch, Jared R and Lah, James J and Brickman, Adam M and Cash, David M and Fox, Nick C and Graff-Radford, Neill R and Levin, Johannes and Noble, James and Holtzman, David M and Masters, Colin L and Farlow, Martin R and Laske, Christoph and Schofield, Peter R and Marcus, Daniel S and Morris, John C and Benzinger, Tammie L S and Bateman, Randall J and Ances, Beau M},
  title = {Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease},
  journal = {Brain Connectivity},
  year = {2021},
  volume = {11},
  number = {3},
  pages = {239--249},
  doi = {10.1089/brain.2020.0808}
}
Kostenlos starten →